Already highly accomplished in her field, the Association for Computing Machinery presented Randles in 2017 with the Grace Murray Hopper Award, given annually to an outstanding young computer professional for a single recent major technical or service contribution.
Randles created computer code that can model the entire arterial system at a subcellular resolution, something that can help show areas in the body where vascular disease may occur. She named the code HARVEY – after William Harvey, the 17th century physician who was the first doctor to accurately describe how blood was pumped around the body by the heart.
MIT Technology Review also named Randles as one of 2017’s “Innovators under 35” and a “visionary” for her work on HARVEY, which has continued to evolve. To make HARVEY more accessible to those in the sciences and medicine, Randles and the Duke team recently introduced a graphical user interface, called Harvis, described in a study published in the Journal of Computational Science.
The ventilator splitter project was something very different for Randles. But it was also something she very much wanted to do when colleague Bishawi asked for her help.
“When we first went on lockdown for COVID-19, I didn’t think there was any way of contributing,” she says. “I wanted to do something useful. With the ventilator splitter, I thought it was exciting that there was actually a way that we could concretely have an impact.”
That immediacy and impact to make things better was among the reasons AI for Health was so interested in the project. Part of the AI for Good initiative, AI for Health is a $60 million, five-year program to empower researchers and organizations with AI to improve the health of people and communities around the world. The program was developed in collaboration with leading health experts who are driving important medical initiatives.
Since April, AI for Health has awarded more than 150 grants to COVID-19 projects around the world.
“One of the things we’re really focused on in AI for Health is societal impact,” Miller says. “Amanda’s project maps very well into our strategy for COVID-19, where one of the areas we’re thinking about is allocation of resources, how to do things like allocate ventilators and ICU beds and PPE (personal protective equipment).”
The FDA has not yet approved the emergency use authorization of the ventilator splitter resistor system, but Randles finds some comfort in that.
“It’s positive that we keep getting put on the back burner,” she says. “That means they don’t need it right this second.”
But if they do, plans can quickly be put into place.
“This work is incredibly important,” Randles says. “The number of cases of COVID-19 are rising. There’s still a finite number of ventilators available, and as we’re starting to push that capacity, doctors need more options, more capabilities and they need more data. And we’re providing them information that’s critical and will hopefully improve patient outcome and patient care.”



